187 related articles for article (PubMed ID: 32749467)
21. Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS; Patel PR; Curran WJ; Shu HG; Sica GL; Higgins KA
Cancer; 2018 Sep; 124(17):3586-3595. PubMed ID: 30120912
[TBL] [Abstract][Full Text] [Related]
22. CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource Utilization.
Chooback N; Lefresne S; Lau SC; Ho C
J Oncol Pract; 2018 Oct; 14(10):e612-e620. PubMed ID: 30216125
[TBL] [Abstract][Full Text] [Related]
23. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.
Ying S; Ke H; Ding Y; Liu Y; Tang X; Yang D; Li M; Liu J; Yu B; Xiang J; Mao X; Han-Zhang H; Hu W; Chen L
Cancer Biol Ther; 2019; 20(4):562-570. PubMed ID: 30395779
[TBL] [Abstract][Full Text] [Related]
24. Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.
Shen F; Liang N; Fan Z; Zhao M; Kang J; Wang X; Hu Q; Mu Y; Wang K; Yuan M; Chen R; Guo W; Dong G; Zhao J; Bai J
Front Oncol; 2022; 12():889591. PubMed ID: 35814426
[TBL] [Abstract][Full Text] [Related]
25. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.
Zorofchian S; Iqbal F; Rao M; Aung PP; Esquenazi Y; Ballester LY
J Clin Pathol; 2019 Apr; 72(4):271-280. PubMed ID: 30467241
[TBL] [Abstract][Full Text] [Related]
26. Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing.
Zhao Y; He JY; Cui JZ; Meng ZQ; Zou YL; Guo XS; Chen X; Wang X; Yan LT; Han WX; Li C; Guo L; Bu H
BMC Cancer; 2020 Jul; 20(1):690. PubMed ID: 32711494
[TBL] [Abstract][Full Text] [Related]
27. [Clinical Value of Droplet Digital PCR and Super-ARMS Detection of Epidermal Growth Factor Receptor Gene Mutation in Plasma Circulating Tumor DNA of Patients with Advanced Lung Adenocarcinoma].
Cao Z; Wang J; Qin N; Li K; Lv J; Wang J; Yang X; Li X; Zhang H; Zhang Q; Long H; Shu C; Ma L; Zhang S
Zhongguo Fei Ai Za Zhi; 2020 Feb; 23(2):84-90. PubMed ID: 32093452
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Wang F; Zhao N; Gao G; Deng HB; Wang ZH; Deng LL; Yang Y; Lu C
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2851-2859. PubMed ID: 32743759
[TBL] [Abstract][Full Text] [Related]
29. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid.
Gu W; Rauschecker AM; Hsu E; Zorn KC; Sucu Y; Federman S; Gopez A; Arevalo S; Sample HA; Talevich E; Nguyen ED; Gottschall M; Nourbakhsh B; Gold CA; Cree BAC; Douglas VC; Richie MB; Shah MP; Josephson SA; Gelfand JM; Miller S; Wang L; Tihan T; DeRisi JL; Chiu CY; Wilson MR
JAMA Neurol; 2021 Nov; 78(11):1355-1366. PubMed ID: 34515766
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of EGFR-TKIs with or without upfront brain radiotherapy for EGFR-mutant NSCLC patients with central nervous system metastases.
Saida Y; Watanabe S; Abe T; Shoji S; Nozaki K; Ichikawa K; Kondo R; Koyama K; Miura S; Tanaka H; Okajima M; Terada M; Ishida T; Tsukada H; Makino M; Iwashima A; Sato K; Matsumoto N; Yoshizawa H; Kikuchi T
Thorac Cancer; 2019 Nov; 10(11):2106-2116. PubMed ID: 31507098
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract][Full Text] [Related]
32. Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.
Schwaederlé MC; Patel SP; Husain H; Ikeda M; Lanman RB; Banks KC; Talasaz A; Bazhenova L; Kurzrock R
Clin Cancer Res; 2017 Sep; 23(17):5101-5111. PubMed ID: 28539465
[No Abstract] [Full Text] [Related]
33. Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC.
Zheng MM; Li YS; Jiang BY; Tu HY; Tang WF; Yang JJ; Zhang XC; Ye JY; Yan HH; Su J; Zhou Q; Zhong WZ; Yang XN; Guo WB; Chuai S; Zhang Z; Chen HJ; Wang Z; Liu C; Wu YL
J Thorac Oncol; 2019 May; 14(5):924-932. PubMed ID: 30659989
[TBL] [Abstract][Full Text] [Related]
34. EGFR mutation status of paired cerebrospinal fluid and plasma samples in EGFR mutant non-small cell lung cancer with leptomeningeal metastases.
Zhao J; Ye X; Xu Y; Chen M; Zhong W; Sun Y; Yang Z; Zhu G; Gu Y; Wang M
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1305-1310. PubMed ID: 27770237
[TBL] [Abstract][Full Text] [Related]
35. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of central nervous system metastases after acquired resistance to EGFR-TKI: poorer prognosis associated with T790M-negative status and leptomeningeal metastases.
Hata A; Katakami N; Yoshioka H; Takeshita J; Tanaka K; Masago K; Fujita S; Kaji R; Imai Y; Monden K; Matsumoto T; Nagata K; Otsuka K; Tachikawa R; Tomii K; Kunimasa K; Iwasaku M; Nishiyama A; Ishida T; Nishimura Y
Anticancer Res; 2015 Feb; 35(2):1025-31. PubMed ID: 25667490
[TBL] [Abstract][Full Text] [Related]
37. Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series.
Metro G; Lunardi G; Bennati C; Chiarini P; Sperduti I; Ricciuti B; Marcomigni L; Costa C; Crinò L; Floridi P; Gori S; Chiari R
J Neurooncol; 2016 Sep; 129(2):355-61. PubMed ID: 27324494
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer subtypes and outcomes of central nervous system metastases.
Arslan UY; Oksuzoglu B; Aksoy S; Harputluoglu H; Turker I; Ozisik Y; Dizdar O; Altundag K; Alkis N; Zengin N
Breast; 2011 Dec; 20(6):562-7. PubMed ID: 21871802
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors.
Takayasu T; Shah M; Dono A; Yan Y; Borkar R; Putluri N; Zhu JJ; Hama S; Yamasaki F; Tahara H; Sugiyama K; Kurisu K; Esquenazi Y; Ballester LY
Sci Rep; 2020 Aug; 10(1):14326. PubMed ID: 32868820
[TBL] [Abstract][Full Text] [Related]
40. The epidermal growth factor receptor-tyrosine kinase inhibitor era has changed the causes of death of patients with advanced non-small-cell lung cancer.
Wu WS; Chen YM; Tsai CM; Shih JF; Lee YC; Perng RP; Whang-Peng J
J Chin Med Assoc; 2013 Dec; 76(12):682-5. PubMed ID: 24064329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
